Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
FDA Issues New Rules For Approving Tobacco Products For The Market October 5, 2021 Martha Garcia Add Your Comments Two new rules have been issued regarding the approval of tobacco products in the U.S., such as e-cigarettes and traditional cigarettes, one of which requires federal regulators to consider the benefits and risks to the population as a whole. The Food and Drug Administration (FDA) issued the two final rules for the premarket review of new tobacco products on October 4, which will help establish new requirements for how tobacco products, including e-cigarettes, are approved by the agency. One of the new rules includes a requirement that additional information be provided for Premarket Tobacco product Applications (PMTAs) and the other for Substantial Equivalence Reports (SERs). These are the two most common avenues manufacturers use to receive approval for new tobacco products from the FDA. Learn More About JUUL and E-Cigarette Lawsuits Nicotine addiction and severe lung injuries from JUUL and vaping products have resulted in lawsuits against manufacturers of e-cigarettes. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About JUUL and E-Cigarette Lawsuits Nicotine addiction and severe lung injuries from JUUL and vaping products have resulted in lawsuits against manufacturers of e-cigarettes. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The PMTA rule requires manufacturers and importers of tobacco products to prove the new product is “appropriate for the protection of the public health.” The new rule calls for the FDA to consider the risks and benefits of the population as a whole. The evaluation of risk versus benefit includes reviewing the products’ components, ingredients, additives, toxicological profile, and overall health impact. It also focuses on how the product is manufactured, packaged, and labeled. The PMTA rule is supposedly designed to ensure there is enough evidence for the FDA to evaluate the product appropriately. The rule also includes information on how a manufacturer can submit a supplemental PMTA or a resubmission, such as for a modified version of a product that has already been reviewed or approved. The SER is the most common pathway for most tobacco products including vapes, cigarettes, hookah, rolled tobacco, and cigars. This new SER rule requires the FDA to find a new product to be “substantially equivalent” to an existing product before it is approved. This means it must have the same characteristics as a prior tobacco product which was approved; or it has different characteristics, but the differences do not cause the new product to raise different concerns regarding public health. This means that if a tobacco product manufacturer does not want to go through the PMTA process and show their product is not a liability to public health, they must take the SER track and show their product is essentially the same as something else already on the market. “These final rules are important components of the FDA’s comprehensive approach to tobacco product regulation, which includes premarket application review, science-based use of the product standard authority and prioritized compliance and enforcement actions,” Acting FDA Commissioner Dr. Janet Woodcock, said in the press release. “The FDA is committed to protecting Americans from tobacco-related disease and death by ensuring that new tobacco products undergo appropriate regulatory review to determine if they meet the public health standards set by law. If new tobacco products do not meet the standards for these pathways, they cannot be marketed or sold in the United States.” The new rules are scheduled to be published October 5 and November 4. FDA Premarket Review of Tobacco Products Continues The FDA is currently conducting premarket review of thousands of tobacco products, which represent more than 6.5 million products overall. So far, the agency has taken action on 96% of the applications submitted before a deadline last month, including denials for more than one million flavored e-cigarettes. The move is part of the agency’s response to growing youth nicotine addiction rates. The FDA used its oversight authority under section 910 of the Federal Food, Drug, and Cosmetic Act to claim regulatory responsibility of all Electronic Nicotine Delivery Systems (ENDS) in 2016, which includes e-cigarettes, vaping products, and all liquids used with the devices. As a result of the action, the FDA mandated that all new and existing nicotine based e-cigarette and vaping products go through premarket tobacco product applications (PMTAs). Under the new rules, manufacturers must provide evidence their vaping products benefit adult smokers enough to overcome the public health threat they represent to youth, as well as how they intended to prevent the lithium ion batteries from exploding. Failure to do so means the products will likely be banned from the market. However, the FDA has yet to issue a final ruling regarding JUUL products, which studies have shown are as addictive as smoking Marlboro cigarettes and have higher nicotine delivery rates than other e-cigarettes. Given JUUL’s massive share of the vaping market, it is probably the most highly anticipated of the rulings. Currently, more than 4,500 JUUL lawsuits are being pursued against the company by individuals, school districts and municipalities, each involving similar allegations that the e-cigarette manufacturer caused a new generation of teens and young adults to become addicted to nicotine by encouraging minors or prior non-smokers to use their vaping products. JUUL is currently facing allegations claiming the manufacturer mined the middle and high school environments with easily concealable USB-like vaping products containing a highly addictive nicotine salt formulation in an effort to make life-long customers out of children. Tags: Electronic Cigarettes, Juul, Nicotine Addiction, Smokers, Tobacco, Vaping More JUUL E-Cigarette Vape Lawsuit Stories More Than Half of U.S. Teens Who Vape Do So To Deal With Stress, Anxiety: Study November 18, 2024 On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024 Vaping Causes Same DNA Damage as Smoking, Study Finds April 12, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 3 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025) Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: 3 days ago) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025) Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 4 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)
On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024
Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 3 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)
Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: 3 days ago) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025)
Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 4 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)